+1 347 708 0418
Antiprotozoal Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antiprotozoal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Diseases
Amoebic Dysentery
Antimalarial Drug
Leishmaniasis & Chagas Disease
by Drugs
Metronidazole
Atovaquone
Benznidazole
Dehydroemetine
Eflornithine
Emetine
Fenbendazole
Iodoquinol
Melarsoprol
Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)
Segment by Application
Hospital
Clinic
By Company
Sanofi
Akthelia Pharmaceuticals Ltd
GlaxoSmithKline Plc
Immuron Ltd
Microbiotix Inc
Protein Potential LLC
Dr. Reddys Laboratories
Mission Pharmacal
Aceto Corp.
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Gilead Sciences
Johnson & Johnson
Bristol-Myers Squibb
Profounda
Knight Therapeutics
Albert David
Wanlong
Fangsheng
KPC Pharmaceuticals
Guilin Pharmaceuticals
Pude Pharmaceutica
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Amoebic Dysentery
1.2.3 Antimalarial Drug
1.2.4 Leishmaniasis & Chagas Disease
1.3 Market by Application
1.3.1 Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antiprotozoal Drugs Market Perspective (2017-2028)
2.2 Antiprotozoal Drugs Growth Trends by Region
2.2.1 Antiprotozoal Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2017-2022)
2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2023-2028)
2.3 Antiprotozoal Drugs Market Dynamics
2.3.1 Antiprotozoal Drugs Industry Trends
2.3.2 Antiprotozoal Drugs Market Drivers
2.3.3 Antiprotozoal Drugs Market Challenges
2.3.4 Antiprotozoal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiprotozoal Drugs Players by Revenue
3.1.1 Global Top Antiprotozoal Drugs Players by Revenue (2017-2022)
3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiprotozoal Drugs Revenue
3.4 Global Antiprotozoal Drugs Market Concentration Ratio
3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2021
3.5 Antiprotozoal Drugs Key Players Head office and Area Served
3.6 Key Players Antiprotozoal Drugs Product Solution and Service
3.7 Date of Enter into Antiprotozoal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiprotozoal Drugs Breakdown Data by Type
4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2017-2022)
4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2023-2028)
5 Antiprotozoal Drugs Breakdown Data by Application
5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2017-2022)
5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antiprotozoal Drugs Market Size (2017-2028)
6.2 North America Antiprotozoal Drugs Market Size by Type
6.2.1 North America Antiprotozoal Drugs Market Size by Type (2017-2022)
6.2.2 North America Antiprotozoal Drugs Market Size by Type (2023-2028)
6.2.3 North America Antiprotozoal Drugs Market Share by Type (2017-2028)
6.3 North America Antiprotozoal Drugs Market Size by Application
6.3.1 North America Antiprotozoal Drugs Market Size by Application (2017-2022)
6.3.2 North America Antiprotozoal Drugs Market Size by Application (2023-2028)
6.3.3 North America Antiprotozoal Drugs Market Share by Application (2017-2028)
6.4 North America Antiprotozoal Drugs Market Size by Country
6.4.1 North America Antiprotozoal Drugs Market Size by Country (2017-2022)
6.4.2 North America Antiprotozoal Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antiprotozoal Drugs Market Size (2017-2028)
7.2 Europe Antiprotozoal Drugs Market Size by Type
7.2.1 Europe Antiprotozoal Drugs Market Size by Type (2017-2022)
7.2.2 Europe Antiprotozoal Drugs Market Size by Type (2023-2028)
7.2.3 Europe Antiprotozoal Drugs Market Share by Type (2017-2028)
7.3 Europe Antiprotozoal Drugs Market Size by Application
7.3.1 Europe Antiprotozoal Drugs Market Size by Application (2017-2022)
7.3.2 Europe Antiprotozoal Drugs Market Size by Application (2023-2028)
7.3.3 Europe Antiprotozoal Drugs Market Share by Application (2017-2028)
7.4 Europe Antiprotozoal Drugs Market Size by Country
7.4.1 Europe Antiprotozoal Drugs Market Size by Country (2017-2022)
7.4.2 Europe Antiprotozoal Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiprotozoal Drugs Market Size (2017-2028)
8.2 Asia-Pacific Antiprotozoal Drugs Market Size by Type
8.2.1 Asia-Pacific Antiprotozoal Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antiprotozoal Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antiprotozoal Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Antiprotozoal Drugs Market Size by Application
8.3.1 Asia-Pacific Antiprotozoal Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antiprotozoal Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antiprotozoal Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Antiprotozoal Drugs Market Size by Region
8.4.1 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antiprotozoal Drugs Market Size (2017-2028)
9.2 Latin America Antiprotozoal Drugs Market Size by Type
9.2.1 Latin America Antiprotozoal Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Antiprotozoal Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Antiprotozoal Drugs Market Share by Type (2017-2028)
9.3 Latin America Antiprotozoal Drugs Market Size by Application
9.3.1 Latin America Antiprotozoal Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Antiprotozoal Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Antiprotozoal Drugs Market Share by Application (2017-2028)
9.4 Latin America Antiprotozoal Drugs Market Size by Country
9.4.1 Latin America Antiprotozoal Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Antiprotozoal Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiprotozoal Drugs Market Size (2017-2028)
10.2 Middle East & Africa Antiprotozoal Drugs Market Size by Type
10.2.1 Middle East & Africa Antiprotozoal Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antiprotozoal Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antiprotozoal Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Antiprotozoal Drugs Market Size by Application
10.3.1 Middle East & Africa Antiprotozoal Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antiprotozoal Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antiprotozoal Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Antiprotozoal Drugs Market Size by Country
10.4.1 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Antiprotozoal Drugs Introduction
11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Akthelia Pharmaceuticals Ltd
11.2.1 Akthelia Pharmaceuticals Ltd Company Details
11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
11.2.5 Akthelia Pharmaceuticals Ltd Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2017-2022)
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Immuron Ltd
11.4.1 Immuron Ltd Company Details
11.4.2 Immuron Ltd Business Overview
11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
11.4.5 Immuron Ltd Recent Developments
11.5 Microbiotix Inc
11.5.1 Microbiotix Inc Company Details
11.5.2 Microbiotix Inc Business Overview
11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2017-2022)
11.5.5 Microbiotix Inc Recent Developments
11.6 Protein Potential LLC
11.6.1 Protein Potential LLC Company Details
11.6.2 Protein Potential LLC Business Overview
11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2017-2022)
11.6.5 Protein Potential LLC Recent Developments
11.7 Dr. Reddys Laboratories
11.7.1 Dr. Reddys Laboratories Company Details
11.7.2 Dr. Reddys Laboratories Business Overview
11.7.3 Dr. Reddys Laboratories Antiprotozoal Drugs Introduction
11.7.4 Dr. Reddys Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
11.7.5 Dr. Reddys Laboratories Recent Developments
11.8 Mission Pharmacal
11.8.1 Mission Pharmacal Company Details
11.8.2 Mission Pharmacal Business Overview
11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2017-2022)
11.8.5 Mission Pharmacal Recent Developments
11.9 Aceto Corp.
11.9.1 Aceto Corp. Company Details
11.9.2 Aceto Corp. Business Overview
11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2017-2022)
11.9.5 Aceto Corp. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Details
11.11.2 Impax Laboratories Business Overview
11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
11.11.5 Impax Laboratories Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Antiprotozoal Drugs Introduction
11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2017-2022)
11.12.5 Pfizer Recent Developments
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Details
11.13.2 Lupin Pharmaceuticals Business Overview
11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.13.5 Lupin Pharmaceuticals Recent Developments
11.14 Glenmark Pharmaceuticals
11.14.1 Glenmark Pharmaceuticals Company Details
11.14.2 Glenmark Pharmaceuticals Business Overview
11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.14.5 Glenmark Pharmaceuticals Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2017-2022)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Heritage Pharmaceuticals
11.16.1 Heritage Pharmaceuticals Company Details
11.16.2 Heritage Pharmaceuticals Business Overview
11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.16.5 Heritage Pharmaceuticals Recent Developments
11.17 Gilead Sciences
11.17.1 Gilead Sciences Company Details
11.17.2 Gilead Sciences Business Overview
11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2017-2022)
11.17.5 Gilead Sciences Recent Developments
11.18 Johnson & Johnson
11.18.1 Johnson & Johnson Company Details
11.18.2 Johnson & Johnson Business Overview
11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2017-2022)
11.18.5 Johnson & Johnson Recent Developments
11.19 Bristol-Myers Squibb
11.19.1 Bristol-Myers Squibb Company Details
11.19.2 Bristol-Myers Squibb Business Overview
11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2017-2022)
11.19.5 Bristol-Myers Squibb Recent Developments
11.20 Profounda
11.20.1 Profounda Company Details
11.20.2 Profounda Business Overview
11.20.3 Profounda Antiprotozoal Drugs Introduction
11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2017-2022)
11.20.5 Profounda Recent Developments
11.21 Knight Therapeutics
11.21.1 Knight Therapeutics Company Details
11.21.2 Knight Therapeutics Business Overview
11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2017-2022)
11.21.5 Knight Therapeutics Recent Developments
11.22 Albert David
11.22.1 Albert David Company Details
11.22.2 Albert David Business Overview
11.22.3 Albert David Antiprotozoal Drugs Introduction
11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2017-2022)
11.22.5 Albert David Recent Developments
11.23 Wanlong
11.23.1 Wanlong Company Details
11.23.2 Wanlong Business Overview
11.23.3 Wanlong Antiprotozoal Drugs Introduction
11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2017-2022)
11.23.5 Wanlong Recent Developments
11.24 Fangsheng
11.24.1 Fangsheng Company Details
11.24.2 Fangsheng Business Overview
11.24.3 Fangsheng Antiprotozoal Drugs Introduction
11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2017-2022)
11.24.5 Fangsheng Recent Developments
11.25 KPC Pharmaceuticals
11.25.1 KPC Pharmaceuticals Company Details
11.25.2 KPC Pharmaceuticals Business Overview
11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.25.5 KPC Pharmaceuticals Recent Developments
11.26 Guilin Pharmaceuticals
11.26.1 Guilin Pharmaceuticals Company Details
11.26.2 Guilin Pharmaceuticals Business Overview
11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
11.26.5 Guilin Pharmaceuticals Recent Developments
11.27 Pude Pharmaceutica
11.27.1 Pude Pharmaceutica Company Details
11.27.2 Pude Pharmaceutica Business Overview
11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2017-2022)
11.27.5 Pude Pharmaceutica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Amoebic Dysentery
Table 3. Key Players of Antimalarial Drug
Table 4. Key Players of Leishmaniasis & Chagas Disease
Table 5. Global Antiprotozoal Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Antiprotozoal Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Antiprotozoal Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Antiprotozoal Drugs Market Share by Region (2017-2022)
Table 9. Global Antiprotozoal Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Antiprotozoal Drugs Market Share by Region (2023-2028)
Table 11. Antiprotozoal Drugs Market Trends
Table 12. Antiprotozoal Drugs Market Drivers
Table 13. Antiprotozoal Drugs Market Challenges
Table 14. Antiprotozoal Drugs Market Restraints
Table 15. Global Antiprotozoal Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Antiprotozoal Drugs Revenue Share by Players (2017-2022)
Table 17. Global Top Antiprotozoal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2021)
Table 18. Ranking of Global Top Antiprotozoal Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiprotozoal Drugs Product Solution and Service
Table 22. Date of Enter into Antiprotozoal Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Antiprotozoal Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Antiprotozoal Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Antiprotozoal Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Antiprotozoal Drugs Revenue Share by Application (2017-2022)
Table 30. Global Antiprotozoal Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Antiprotozoal Drugs Revenue Share by Application (2023-2028)
Table 32. North America Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Antiprotozoal Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Antiprotozoal Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Antiprotozoal Drugs Product
Table 65. Sanofi Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 66. Sanofi Recent Developments
Table 67. Akthelia Pharmaceuticals Ltd Company Details
Table 68. Akthelia Pharmaceuticals Ltd Business Overview
Table 69. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product
Table 70. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 71. Akthelia Pharmaceuticals Ltd Recent Developments
Table 72. GlaxoSmithKline Plc Company Details
Table 73. GlaxoSmithKline Plc Business Overview
Table 74. GlaxoSmithKline Plc Antiprotozoal Drugs Product
Table 75. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 76. GlaxoSmithKline Plc Recent Developments
Table 77. Immuron Ltd Company Details
Table 78. Immuron Ltd Business Overview
Table 79. Immuron Ltd Antiprotozoal Drugs Product
Table 80. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 81. Immuron Ltd Recent Developments
Table 82. Microbiotix Inc Company Details
Table 83. Microbiotix Inc Business Overview
Table 84. Microbiotix Inc Antiprotozoal Drugs Product
Table 85. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 86. Microbiotix Inc Recent Developments
Table 87. Protein Potential LLC Company Details
Table 88. Protein Potential LLC Business Overview
Table 89. Protein Potential LLC Antiprotozoal Drugs Product
Table 90. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 91. Protein Potential LLC Recent Developments
Table 92. Dr. Reddys Laboratories Company Details
Table 93. Dr. Reddys Laboratories Business Overview
Table 94. Dr. Reddys Laboratories Antiprotozoal Drugs Product
Table 95. Dr. Reddys Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 96. Dr. Reddys Laboratories Recent Developments
Table 97. Mission Pharmacal Company Details
Table 98. Mission Pharmacal Business Overview
Table 99. Mission Pharmacal Antiprotozoal Drugs Product
Table 100. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 101. Mission Pharmacal Recent Developments
Table 102. Aceto Corp. Company Details
Table 103. Aceto Corp. Business Overview
Table 104. Aceto Corp. Antiprotozoal Drugs Product
Table 105. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 106. Aceto Corp. Recent Developments
Table 107. Mylan Pharmaceuticals Company Details
Table 108. Mylan Pharmaceuticals Business Overview
Table 109. Mylan Pharmaceuticals Antiprotozoal Drugs Product
Table 110. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 111. Mylan Pharmaceuticals Recent Developments
Table 112. Impax Laboratories Company Details
Table 113. Impax Laboratories Business Overview
Table 114. Impax Laboratories Antiprotozoal Drugs Product
Table 115. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 116. Impax Laboratories Recent Developments
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Antiprotozoal Drugs Product
Table 120. Pfizer Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 121. Pfizer Recent Developments
Table 122. Lupin Pharmaceuticals Company Details
Table 123. Lupin Pharmaceuticals Business Overview
Table 124. Lupin Pharmaceuticals Antiprotozoal Drugs Product
Table 125. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 126. Lupin Pharmaceuticals Recent Developments
Table 127. Glenmark Pharmaceuticals Company Details
Table 128. Glenmark Pharmaceuticals Business Overview
Table 129. Glenmark Pharmaceuticals Antiprotozoal Drugs Product
Table 130. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 131. Glenmark Pharmaceuticals Recent Developments
Table 132. Sun Pharmaceutical Company Details
Table 133. Sun Pharmaceutical Business Overview
Table 134. Sun Pharmaceutical Antiprotozoal Drugs Product
Table 135. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 136. Sun Pharmaceutical Recent Developments
Table 137. Heritage Pharmaceuticals Company Details
Table 138. Heritage Pharmaceuticals Business Overview
Table 139. Heritage Pharmaceuticals Antiprotozoal Drugs Product
Table 140. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 141. Heritage Pharmaceuticals Recent Developments
Table 142. Gilead Sciences Company Details
Table 143. Gilead Sciences Business Overview
Table 144. Gilead Sciences Antiprotozoal Drugs Product
Table 145. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 146. Gilead Sciences Recent Developments
Table 147. Johnson & Johnson Company Details
Table 148. Johnson & Johnson Business Overview
Table 149. Johnson & Johnson Antiprotozoal Drugs Product
Table 150. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 151. Johnson & Johnson Recent Developments
Table 152. Bristol-Myers Squibb Company Details
Table 153. Bristol-Myers Squibb Business Overview
Table 154. Bristol-Myers Squibb Antiprotozoal Drugs Product
Table 155. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 156. Bristol-Myers Squibb Recent Developments
Table 157. Profounda Company Details
Table 158. Profounda Business Overview
Table 159. Profounda Antiprotozoal Drugs Product
Table 160. Profounda Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 161. Profounda Recent Developments
Table 162. Knight Therapeutics Company Details
Table 163. Knight Therapeutics Business Overview
Table 164. Knight Therapeutics Antiprotozoal Drugs Product
Table 165. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 166. Knight Therapeutics Recent Developments
Table 167. Albert David Company Details
Table 168. Albert David Business Overview
Table 169. Albert David Antiprotozoal Drugs Product
Table 170. Albert David Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 171. Albert David Recent Developments
Table 172. Wanlong Company Details
Table 173. Wanlong Business Overview
Table 174. Wanlong Antiprotozoal Drugs Product
Table 175. Wanlong Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 176. Wanlong Recent Developments
Table 177. Fangsheng Company Details
Table 178. Fangsheng Business Overview
Table 179. Fangsheng Antiprotozoal Drugs Product
Table 180. Fangsheng Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 181. Fangsheng Recent Developments
Table 182. KPC Pharmaceuticals Company Details
Table 183. KPC Pharmaceuticals Business Overview
Table 184. KPC Pharmaceuticals Antiprotozoal Drugs Product
Table 185. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 186. KPC Pharmaceuticals Recent Developments
Table 187. Guilin Pharmaceuticals Company Details
Table 188. Guilin Pharmaceuticals Business Overview
Table 189. Guilin Pharmaceuticals Antiprotozoal Drugs Product
Table 190. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 191. Guilin Pharmaceuticals Recent Developments
Table 192. Pude Pharmaceutica Company Details
Table 193. Pude Pharmaceutica Business Overview
Table 194. Pude Pharmaceutica Antiprotozoal Drugs Product
Table 195. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
Table 196. Pude Pharmaceutica Recent Developments
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiprotozoal Drugs Market Share by Type: 2021 VS 2028
Figure 2. Amoebic Dysentery Features
Figure 3. Antimalarial Drug Features
Figure 4. Leishmaniasis & Chagas Disease Features
Figure 5. Global Antiprotozoal Drugs Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Antiprotozoal Drugs Report Years Considered
Figure 9. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Antiprotozoal Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Antiprotozoal Drugs Market Share by Region: 2021 VS 2028
Figure 12. Global Antiprotozoal Drugs Market Share by Players in 2021
Figure 13. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2021
Figure 15. North America Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
Figure 17. North America Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
Figure 18. North America Antiprotozoal Drugs Market Size Share by Country (2017-2028)
Figure 19. United States Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
Figure 23. Europe Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
Figure 24. Europe Antiprotozoal Drugs Market Size Share by Country (2017-2028)
Figure 25. Germany Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Antiprotozoal Drugs Market Size Share by Region (2017-2028)
Figure 35. China Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Antiprotozoal Drugs Market Size Share by Country (2017-2028)
Figure 45. Mexico Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Antiprotozoal Drugs Market Size Share by Country (2017-2028)
Figure 51. Turkey Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 55. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 56. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 57. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 58. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 59. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 60. Dr. Reddys Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 61. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 62. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 63. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 64. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 67. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 68. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 69. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 70. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 71. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 73. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 74. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 75. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 76. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 77. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 78. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 79. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 80. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
Buy
